FDA label
What is Lantus used for?
Lantus contains insulin glargine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Lantus?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lantus, injection, solution
Indications and Usage, quoted from the label by sanofi-aventis U.S. LLC (BLA021081). Cross-references to other label sections are left out.
LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Limitations of Use
LANTUS is not recommended for the treatment of diabetic ketoacidosis.
Source: DailyMed label, set id d5e07a0c-7e14-4756-9152-9fea485d654a, version 35, effective June 2, 2025. NDC 0088-2220, one of 2 listings for this product.
Questions
What is Lantus used for?
The FDA label says: “LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
What drug class is Lantus?
FDA lists insulin glargine in the Insulin Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.